- Phare
- Validé par KD/KO
Anticorps Polyclonal de lapin anti-FABP4
FABP4 Polyclonal Antibody for WB, IF/ICC, ELISA
Hôte / Isotype
Lapin / IgG
Réactivité testée
Humain, rat, souris
Applications
WB, IF/ICC, ELISA
Conjugaison
Non conjugué
N° de cat : 31129-1-AP
Synonymes
Galerie de données de validation
Applications testées
| Résultats positifs en WB | tissu de muscle squelettique de souris, tissu cardiaque de rat, tissu de muscle squelettique de rat |
| Résultats positifs en IF/ICC | cellules 3T3-L1, |
Dilution recommandée
| Application | Dilution |
|---|---|
| Western Blot (WB) | WB : 1:500-1:3000 |
| Immunofluorescence (IF)/ICC | IF/ICC : 1:200-1:800 |
| It is recommended that this reagent should be titrated in each testing system to obtain optimal results. | |
| Sample-dependent, check data in validation data gallery | |
Informations sur le produit
31129-1-AP cible FABP4 dans les applications de WB, IF/ICC, ELISA et montre une réactivité avec des échantillons Humain, rat, souris
| Réactivité | Humain, rat, souris |
| Hôte / Isotype | Lapin / IgG |
| Clonalité | Polyclonal |
| Type | Anticorps |
| Immunogène | FABP4 Protéine recombinante Eg0880 |
| Nom complet | fatty acid binding protein 4, adipocyte |
| Masse moléculaire calculée | 15 kDa |
| Poids moléculaire observé | 15 kDa |
| Numéro d’acquisition GenBank | NM_001442.3 |
| Symbole du gène | FABP4 |
| Identification du gène (NCBI) | 2167 |
| Conjugaison | Non conjugué |
| Forme | Liquide |
| Méthode de purification | Purification par affinité contre l'antigène |
| Tampon de stockage | PBS with 0.02% sodium azide and 50% glycerol |
| Conditions de stockage | Stocker à -20°C. Stable pendant un an après l'expédition. L'aliquotage n'est pas nécessaire pour le stockage à -20oC Les 20ul contiennent 0,1% de BSA. |
Informations générales
Fatty acid binding protein (FABP) 4 is a member of the FABP family which abundantly expressed, fatty acid carrier proteins. FABPs are capable of binding a variety of hydrophobic molecules such as long-chain fatty acids and are important for their uptake and intracellular trafficking. It was first identified as an adipocyte-specific protein, important for the maintenance of lipid and glucose metabolism. It is also detected in macrophages, where it participates in regulating inflammation and cholesterol trafficking via NFκB and PPAR. In more recent studies, FABP4 has been found in a variety of endothelial cells, where it has been identified as a target of VEGF and a regulator of cell proliferation and possibly angiogenesis. Pathologically, FABP4 has been associated with the development of metabolic syndrome, diabetes and cancer and vulnerability of atherosclerotic plaques. FABP4 has been identified as a novel prognostic factor for both adverse cardiovascular events and breast cancer.
Protocole
| Product Specific Protocols | |
|---|---|
| WB protocol for FABP4 antibody 31129-1-AP | Download protocol |
| IF protocol for FABP4 antibody 31129-1-AP | Download protocol |
| Standard Protocols | |
|---|---|
| Click here to view our Standard Protocols |


